Chronic Stable Plaque Psoriasis clinical trials

Explore recruiting chronic stable plaque psoriasis clinical trials.

Also recruiting in Europe

Chronic Stable Plaque Psoriasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and of one ointment without active substances for patients with chronic stable plaque poriasis

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Stable Plaque Psoriasis trials by city

Chronic Stable Plaque Psoriasis in Toronto Chronic Stable Plaque Psoriasis in Vancouver Chronic Stable Plaque Psoriasis in Montreal Chronic Stable Plaque Psoriasis in Calgary Chronic Stable Plaque Psoriasis in Edmonton Chronic Stable Plaque Psoriasis in Ottawa Chronic Stable Plaque Psoriasis in Winnipeg Chronic Stable Plaque Psoriasis in Quebec City Chronic Stable Plaque Psoriasis in Hamilton Chronic Stable Plaque Psoriasis in Kitchener Chronic Stable Plaque Psoriasis in London Chronic Stable Plaque Psoriasis in Halifax Chronic Stable Plaque Psoriasis in New York Chronic Stable Plaque Psoriasis in Los Angeles Chronic Stable Plaque Psoriasis in Chicago Chronic Stable Plaque Psoriasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease